137 related articles for article (PubMed ID: 17465200)
21. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.
Goda AE; Yoshida T; Horinaka M; Yasuda T; Shiraishi T; Wakada M; Sakai T
Oncogene; 2008 May; 27(24):3435-45. PubMed ID: 18193086
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin.
Bouralexis S; Clayer M; Atkins GJ; Labrinidis A; Hay S; Graves S; Findlay DM; Evdokiou A
Int J Oncol; 2004 May; 24(5):1263-70. PubMed ID: 15067350
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1.
Fan L; Zhu C; Qiu R; Zan P; Zheng Z; Xu T; Li G
Cell Physiol Biochem; 2017; 41(5):1935-1946. PubMed ID: 28391262
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol Derivative, Trans-3, 5, 4'-Trimethoxystilbene Sensitizes Osteosarcoma Cells to Apoptosis via ROS-Induced Caspases Activation.
Feng Y; Clayton J; Yake W; Li J; Wang W; Winne L; Hong M
Oxid Med Cell Longev; 2021; 2021():8840692. PubMed ID: 33833855
[TBL] [Abstract][Full Text] [Related]
25. Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells.
Matsui TA; Sowa Y; Yoshida T; Murata H; Horinaka M; Wakada M; Nakanishi R; Sakabe T; Kubo T; Sakai T
Carcinogenesis; 2006 Sep; 27(9):1768-77. PubMed ID: 16571651
[TBL] [Abstract][Full Text] [Related]
26. IPS-1 is crucial for DAP3-mediated anoikis induction by caspase-8 activation.
Li HM; Fujikura D; Harada T; Uehara J; Kawai T; Akira S; Reed JC; Iwai A; Miyazaki T
Cell Death Differ; 2009 Dec; 16(12):1615-21. PubMed ID: 19644511
[TBL] [Abstract][Full Text] [Related]
27. Prostate-apoptosis-response-gene-4 increases sensitivity to TRAIL-induced apoptosis.
Boehrer S; Nowak D; Puccetti E; Ruthardt M; Sattler N; Trepohl B; Schneider B; Hoelzer D; Mitrou PS; Chow KU
Leuk Res; 2006 May; 30(5):597-605. PubMed ID: 16513168
[TBL] [Abstract][Full Text] [Related]
28. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Patiño-García A; Zalacain M; Folio C; Zandueta C; Sierrasesúmaga L; San Julián M; Toledo G; De Las Rivas J; Lecanda F
Clin Cancer Res; 2009 Aug; 15(16):5082-91. PubMed ID: 19671856
[TBL] [Abstract][Full Text] [Related]
29. The ERK/eIF4F/Bcl-XL pathway mediates SGP-2 induced osteosarcoma cells apoptosis in vitro and in vivo.
Zhang Z; Zheng Y; Zhu R; Zhu Y; Yao W; Liu W; Gao X
Cancer Lett; 2014 Oct; 352(2):203-13. PubMed ID: 25025927
[TBL] [Abstract][Full Text] [Related]
30. Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas.
Presneau N; Duhamel LA; Ye H; Tirabosco R; Flanagan AM; Eskandarpour M
Br J Cancer; 2017 Jul; 117(3):398-408. PubMed ID: 28632727
[TBL] [Abstract][Full Text] [Related]
31. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
32. A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins.
Miyazaki T; Reed JC
Nat Immunol; 2001 Jun; 2(6):493-500. PubMed ID: 11376335
[TBL] [Abstract][Full Text] [Related]
33. Chrysanthemulide A induces apoptosis through DR5 upregulation via JNK-mediated autophagosome accumulation in human osteosarcoma cells.
Zhuo FF; Zhang C; Zhang H; Xia Y; Xue GM; Yang L; Kong LY
J Cell Physiol; 2019 Aug; 234(8):13191-13208. PubMed ID: 30556589
[TBL] [Abstract][Full Text] [Related]
34. Disrupting mitochondrial Ca2+ homeostasis causes tumor-selective TRAIL sensitization through mitochondrial network abnormalities.
Ohshima Y; Takata N; Suzuki-Karasaki M; Yoshida Y; Tokuhashi Y; Suzuki-Karasaki Y
Int J Oncol; 2017 Oct; 51(4):1146-1158. PubMed ID: 28849210
[TBL] [Abstract][Full Text] [Related]
35. Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma.
Wang Y; Li L; Shao N; Hu Z; Chen H; Xu L; Wang C; Cheng Y; Xiao J
Acta Biomater; 2015 Apr; 17():115-24. PubMed ID: 25595474
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
37. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
38. Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway.
Zhao X; Zhang Q; Chen L
Oncol Rep; 2016 Sep; 36(3):1499-505. PubMed ID: 27461934
[TBL] [Abstract][Full Text] [Related]
39. The secreted protein acidic and rich in cysteine is a critical mediator of cell death program induced by WIN/TRAIL combined treatment in osteosarcoma cells.
Notaro A; Sabella S; Pellerito O; Vento R; Calvaruso G; Giuliano M
Int J Oncol; 2016 Mar; 48(3):1039-44. PubMed ID: 26698404
[TBL] [Abstract][Full Text] [Related]
40. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP.
Rokhlin OW; Guseva NV; Tagiyev AF; Glover RA; Cohen MB
Prostate; 2002 Jun; 52(1):1-11. PubMed ID: 11992615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]